 ALX Oncology Holdings Inc NASDAQ: ALXO shares are trading higher by 19.3 at 74.69, potentially in sympathy with Trillium Therapeutics which announced an acquisition by Pfizer Monday. ALX Oncology is a clinical-stage immuno-oncology company. 